Effective this month, the peptides SYN-AKE and SYN-HYCAN are listed by the Chinese Food & Drug Administration (CFDA). This is the latest addition in the ten years story of DSM’s patented SYN synthetic peptides portfolio. Encouraged by customers that have persistently raised their interest and demand for additional SYN-Peptides, this new listing joins SYN-COLL, which was already listed by CFDA…
